123 related articles for article (PubMed ID: 7001970)
1. COMLA chemotherapy for lymphoma.
Raich PC
Ann Intern Med; 1980 Sep; 93(3):509-10. PubMed ID: 7001970
[No Abstract] [Full Text] [Related]
2. Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma.
Sweet DL; Golomb HM; Ultmann JE; Miller JB; Stein RS; Lester EP; Mintz U; Bitran JD; Streuli RA; Daly K; Roth NO
Ann Intern Med; 1980 Jun; 92(6):785-90. PubMed ID: 6992679
[TBL] [Abstract][Full Text] [Related]
3. The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
Guglielmi C; Amadori S; Martelli M; Papa G; Mandelli F
Leukemia; 1991; 5 Suppl 1():102-4. PubMed ID: 1890858
[No Abstract] [Full Text] [Related]
4. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
[TBL] [Abstract][Full Text] [Related]
5. What constitutes "improved prognosis"?
Canellos GP
J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
[No Abstract] [Full Text] [Related]
6. Combination chemotherapy of non-Hodgkin lymphoma.
Forcier RJ; McIntyre OR; Nissen NI; Pajak TF; Glidewell O; Holland JF
Med Pediatr Oncol; 1978; 4(4):351-62. PubMed ID: 364285
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in chemotherapy of malignancy.
Bertino JR
Laryngoscope; 1975 Mar; 85(3):491-8. PubMed ID: 1091794
[No Abstract] [Full Text] [Related]
8. Prognostic significance of the Lukes and Collins classification in patient treated with COMLA.
Sweet DL; Collins RD; Stein RS; Ultmann JE
Cancer Treat Rep; 1982 May; 66(5):1107-11. PubMed ID: 7044531
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle agents and cyclophosphamide in the treatment of diffuse histiocytic lymphoma.
Gomez GA; Stutzman L
Eur J Cancer (1965); 1978 Oct; 14(10):1051-5. PubMed ID: 361413
[No Abstract] [Full Text] [Related]
10. [Chemotherapy of non-Hodgkin lymphoma with poor prognosis].
Rupniewska ZM; Kurowska M
Pol Arch Med Wewn; 1980 Aug; 64(2):167-79. PubMed ID: 6159608
[No Abstract] [Full Text] [Related]
11. [Chemotherapy of malignant lymphoma].
Horikoshi N; Ogawa M
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1903-10. PubMed ID: 6985187
[TBL] [Abstract][Full Text] [Related]
12. Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimen.
Baer MR; Stein RS; Greer JP; Wolff SN; Hainsworth JD; Flexner JM
Cancer Treat Rep; 1986 Jun; 70(6):785-7. PubMed ID: 3488125
[TBL] [Abstract][Full Text] [Related]
13. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate, cyclophosphamide and vincristine (MEV regimen) for non-Hodgkin's lymphoma.
Lauria F; Baccarani M; Fiacchini M; Gobbi M; Tura S
Eur J Cancer (1965); 1975 May; 11(5):343-9. PubMed ID: 1098915
[No Abstract] [Full Text] [Related]
15. The treatment of histiocytic lymphoma.
Sweet DL; Golomb HM
Semin Oncol; 1980 Sep; 7(3):302-9. PubMed ID: 6774422
[No Abstract] [Full Text] [Related]
16. Letter: Chemotherapy of advanced histocytic lymphomas.
Sweet D; Golomb H; Desser R; Ultmann JE; Yachnin S; Stein R
Lancet; 1975 May; 1(7916):1136. PubMed ID: 49488
[No Abstract] [Full Text] [Related]
17. Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.
Cabanillas F; Rodriguez V; Bodey GP
Cancer Treat Rep; 1980; 64(8-9):933-7. PubMed ID: 7004634
[No Abstract] [Full Text] [Related]
18. Non-Hodgkin lymphoma presenting as a solitary rectal polyp.
Bollen P; Bourgain C; Van Berlaer G; Duville L; Vandenplas Y
J Pediatr Gastroenterol Nutr; 2000 Aug; 31(2):193-4. PubMed ID: 10941976
[No Abstract] [Full Text] [Related]
19. [Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Maruyama D
Rinsho Ketsueki; 2011 Oct; 52(10):1645-54. PubMed ID: 21971242
[No Abstract] [Full Text] [Related]
20. Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites.
Cadman E; Farber L; Berd D; Bertino J
Cancer Treat Rep; 1977 Sep; 61(6):1109-16. PubMed ID: 332346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
